Arcturus Therapeutics Holdings Inc. (ARCT) vs Embecta Corp. (EMBC)

A side-by-side comparison of Arcturus Therapeutics Holdings Inc. and Embecta Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Arcturus Therapeutics Holdings Inc. logo
ARCT
Arcturus Therapeutics Holdings Inc.
$380M
$13.37HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT
Embecta Corp. logo
EMBC
Embecta Corp.
$354M
$5.98HealthcareDelayed quote: Oct 6, 2026, 11:30 AM EDT

Total return — ARCT vs EMBC

growth of $100 · dividends reinvested · last 5y
ARCT -47.4% (-12.1%/yr)EMBC -85.5% (-32.1%/yr)ARCT compounded faster over this window
050100150Start $1002023202420252026$53$14
ARCT EMBC

ARCT vs EMBC: by the numbers

  • •ARCT is the larger company ($380M vs $354M market cap).
  • •EMBC is profitable (8.59% net margin) while ARCT runs a net loss (-391.90%).
  • •ARCT grew revenue faster over the past five years (22.30% vs -0.09% CAGR).
  • •EMBC pays a dividend (5.44% yield), while ARCT is a former payer with no current dividend run rate.

Metrics side by side

Valuation

MetricARCTEMBC
P/E ratioN/A4.04
Forward P/EN/A3.39
P/S ratio15.960.35
P/B ratio2.21N/A
EV / EBITDAN/A5.38
FCF yieldN/A46.43%

Profitability

MetricARCTEMBC
Gross margin95.50%59.89%
Operating margin-111.51%24.85%
Net margin-391.90%8.59%
ROE-54.29%N/A
ROIC-54.07%17.99%

Dividends

MetricARCTEMBC
Dividend yieldN/A5.44%
Payout ratioN/A21.62%

Growth (annualized)

MetricARCTEMBC
Revenue CAGR (5Y)22.30%-0.09%
EPS CAGR (5Y)N/A-26.22%
FCF CAGR (5Y)N/A-16.77%
Total return CAGR (5Y)-18.73%N/A

Frequently asked

Which has grown faster, ARCT or EMBC?
Over the past five years, ARCT grew revenue faster — ARCT at a 22.30% CAGR versus EMBC at -0.09%.
Does ARCT or EMBC pay a bigger dividend?
EMBC pays a dividend (5.44% yield), while ARCT is a former payer with no current dividend run rate.
Is ARCT or EMBC more profitable?
EMBC runs the higher net margin — ARCT at -391.90% versus EMBC at 8.59%.

Go deeper

Full ARCT analysisFull EMBC analysisInteractive comparison tool

Dig into the metrics

Embecta P/E ratioEmbecta dividend yieldArcturus Therapeutics ROEEmbecta ROEArcturus Therapeutics operating marginEmbecta operating marginArcturus Therapeutics revenue growthEmbecta revenue growthArcturus Therapeutics free cash flowEmbecta free cash flow

Arcturus Therapeutics & Embecta appear in these rankings

Highest Dividend Yield StocksFastest Revenue Growth StocksHighest FCF Yield StocksLowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.